NEVER DOUBT A SMALL GROUP OF THOUGHTFUL, COMMITTED CITIZENS CAN CHANGE THE WORLD. INDEED, IT IS THE ONLY THING THAT EVER HAS.
- Margaret Mead
BRIOTECH FOUNDER, CEO
Dan Terry is an inventor and the founder of Briotech, Inc. With 30+ years of experience in design-for-manufacturability of electro-mechanical and mechanical devices, Dan specializes in product and component development, start-up, ramp-up, continuous improvement and supply chain management. He provides solutions in design, manufacturing processes, supplier selection and management, and component supply. Dan’s specialties include 'change agent' review, LED thermal solutions, thermal products, alternative energy in micropower, hydro-power, ethanol distillation, solar, clean coal, hydrogen, IP review and IP development. After four years in development at Danterry, Inc., Briotech, Inc. was spun out as a manufacturer of stable, ultra-pure Hypochlorous Acid (HOCl) for biocide products, the cosmetics industry, animal and human healthcare, hospital disinfection, pathogen control, and the agriculture industries. Briotech’s patent-pending innovations include new electrolysis technology, development of mobile HOCl factory systems for disaster relief and pathogen disinfection spray and fogging systems.
BRIOTECH FOUNDER, EXECUTIVE VICE PRESIDENT
Cynthia Varela is the founder of Briotech, Inc., a global biotechnology company that leads the way in breakthrough production of the world’s first biologically authentic, pure and stable hypochlorous acid (HOCl) formulations. Cynthia serves as the Executive Vice President of Briotech, Inc. and also holds a seat as a member of the Board of Directors. Prior to the creation of Briotech, Cynthia worked for 27 years as an owner and Vice President of Danterry, Inc., a well-established and trusted supplier of fully-fabricated precision components and assemblies to OEMs globally. Cynthia brings a keen sense of business experience in all aspects of administrative and management operations that spans over 39 years and includes the start-up and running of her own multiple companies. As an adept, fast-paced entrepreneur, Cynthia has an eye for strategic control of use of resources in ever-demanding environments, and her wide range of responsibilities includes everything from accounting to finance, human resources, marketing, sales, and customer service. Recognizing the necessity for fluency in business operations, Cynthia strives to design and drive company culture. Cynthia holds a deep, altruistic global vision for Briotech, Inc. that she brings to fruition as the Executive Director of BrioEarth, the humanitarian division of Briotech, Inc. that is dedicated to raising joy by providing Briotech HOCl formulations, and other donation avenues, to vulnerable and impoverished populations of the world via passionate focus on underserved children, at-risk women, communities suffering from racial and economic inequity, first responders and other individuals who are vulnerable to infectious disease, and those who are medically compromised.
BRIOTECH PRESIDENT, CHIEF COMMERCIAL OFFICER
Rick is an executive sales & business development leader, focusing on growth in markets and teams. As a leader he believes in building strong, diverse teams & driving growth through innovation, execution & a relentless focus on achievement. A leader in the clean technology and water treatment markets, Rick has been an Executive and C- Suite leader of early stage & growth companies such as HaloSource (culminated in an IPO), Edgewood Ave (Founded & Sold), Muntech, BioDex Laboratories and Puralytics. Rick’s has built distribution in North American sales channels, developed brands as leaders in their markets and has significant global experience building businesses and customer success internationally in India, Brazil, China, Australia, Europe, SE Asia, the Middle East and other markets with a focus on partnering & technology adoption / licensing. Rick is passionate about the Briotech mission to bring BrioHOCl to the world & is focused daily on accomplishing that mission.
BRIOTECH CHIEF OPERATING OFFICER
Mr. Johnston is an entrepreneurial executive with extensive experience building and launching products and brands in the consumer goods industry. Known for capital raising, global expansions, and M&A with an authentic and data-driven approach to achieving aggressive growth goals in the startup environment. Prior to joining Biotech, Joshua served as CEO of OxiScience LLC, a fast growing startup with patented odor control technology. The flagship brand, NonScents, has received multiple Amazon's Choice listings in the pet and home product categories. During his two years at OxiScience, he grew monthly revenue by over 3x. Prior to OxiScience, he spent 20 years at HaloSource, Inc. in roles across all aspects of business management including Operations, Finance, Marketing, Product Development, Strategy and Information Technology. Highlights of his time at HaloSource were raising $160M of private equity, convertible debt and public market financing, including an $80M IPO on the London Stock Exchange in October 2010, successful formation of subsidiaries for manufacturing and sales in India and China, building out a global supply chain for a new line of contaminant removal water bottles, and leading the divestitures of two business units and the acquisition of a new product line. Joshua graduated from the University of Washington with a Bachelor of Science in Cell and Molecular Biology and from the Foster School of Business with a Master of Business Administration.
JEFF WILLIAMS, PhD, BVSc, MRCVS
BRIOTECH CHIEF SCIENCE OFFICER
Dr. Williams had a long career in academic microbiology and infectious diseases, retiring after 27 years from his position as Professor Emeritus of Microbiology and Molecular Genetics, Michigan State University to found a biotechnology start-up, HaloSource, Inc., in Seattle, WA in 1998. Retiring again in 2014, he has remained active as technical advisor to several companies in the PNW region, specializing in the areas of antimicrobial chemistry and disinfection. Author of over 200 scientific papers and textbook chapters, he served four years as a member of the Board of Counselors to the US-NIH Institute of Allergy and Infectious Diseases, and has been a frequent consultant to the World Health Organization of the UN in Geneva, Switzerland. Jeff was elected Fellow of the American Association for the Advancement of Science (AAAS) in 1996, and served as retained consultant to first Merck, Inc. (1980-1982), then Pharmacia (now Pfizer, Inc.) (1983-1999) on therapeutic drug discovery and development. He has a long standing interest in tropical infectious diseases, starting with his appointment as staff scientist for WHO in Argentina 1968-71, and for 15 years directed a collaborative NIH-funded Program Project on Infectious Diseases in Sudan. He holds degrees in Veterinary Science (BVSc) from the University of Bristol, UK (1964), and Pathobiology (PhD) from the University of Pennsylvania (1968), where he was a Fulbright Scholar (1964-1968).
ERIC RASMUSSEN, MD, MDM, FACP
BRIOTECH CHIEF MEDICAL OFFICER
Dr. Rasmussen is a global expert, consultant and teacher in disaster medicine and response technologies in the US, China, and Germany. He has 25 years of experience as a Navy physician with multiple combat tours in Bosnia, Iraq and Afghanistan, and more conventional medical experience as an Intensive Care Unit Director and Chairman of an academic Department of Medicine. He spent nine years as a Principal Investigator with the Defense Advanced Research Projects Agency (DARPA) and is now the CEO of Infinitum Humanitarian Systems, a humanitarian sciences consulting group with projects in Mexico, Tanzania, Latvia, Nepal, the Philippines, and China. He also leads the global disaster response team for the Roddenberry Foundation, supported by the “Star Trek” franchise, and holds multiple academic, advisory, and public service appointments.
JENNIFER WEINS, BS, MBA
BRIOTECH GLOBAL PROJECT MANAGER
Jennifer is thrilled to join Briotech’s effort and mission in promoting this disruptive technology of pure and stable HOCl to the market, transform healthcare, and to ultimately improve the quality of life around the planet. Her background after her first degree in Neuroscience started as a Bench Scientist turned Department Lead working in both the Biologics R&D and GMP space. This provided a strong Data Science foundation she applies to the wide range of Business Management functions and decisions she makes to this day. After getting her Executive MBA and growing two startups in Boston, she came back to her home state in the PNW looking for the right fit. When the pandemic hit, and an opportunity to join Briotech as a Projects Manager came along, it was an easy decision for Jen to make. With a genuine appreciation for Briotech’s mission and comradery with her new Brio-teammates, she now supports all teams cross-functionally, including Product Management, Manufacturing, Supply Chain, Regulatory, Scientific R&D, Marketing, Safety, BrioEarth, and Organizational Development initiatives so all Briotech business functions are effectively matrixed, harmonized, and supporting one another.
DIRECTOR OF PRODUCTION & SUPPLY CHAIN
Devon is an operations and supply chain leader with a passion for helping companies design/execute highly efficient production operations. He began his career as a plant manager for a niche chemical manufacturer and over the years has managed domestic and international teams involved in the manufacturing of a variety of products ranging from hemostatic bandages to water purification devices. Devon is excited to participate in the mission of getting the life changing Briotech technology into the hands of those that need it the most around the world.
JEREMY STONE, MD, MBA, FRSA, BRIOTECH ADVISOR
Jeremy is a physician, entrepreneur and financier, with international interests in life sciences, aviation, transport, structured finance, healthcare reform and strategy. Trained in the British National Health Service, he has worked globally as investor, Chair, CFO, CEO and COO, yet inside remains a physician with a passion for disruptive life-enhancing innovation.
BRYAN HURD, CISSP, CISA, CISM, CCCI, CCFT, BRIOTECH ADVISOR
Bryan is the Director of Advanced Analytics Cybercrime Center at Microsoft. Bryan is a global expert in strategic response to terrorism, cybercrime and cyber security with 20+ years of experience in military, government civilian and commercial corporation roles. He founded the first cyber counterintelligence program for the US Navy, was in charge of innovation and national data integration for US watchlisting and was the first director of intelligence for Microsoft’s global cybercrime center.